Pediatric Inflammatory Bowel Disease: Highlighting Pediatric Differences in IBD

Gastroenterology Clinics of North America

Volumn 38, Issue 4, 2009, Pages 611-628

  Sauer, Cary G ^a   Kugathasan, Subra ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Crohn disease; Evidence based treatment algorithms; Inflammatory bowel disease; Pediatric; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; IMMUNOMODULATING AGENT; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; PLACEBO; PREDNISONE;

CHILD GROWTH; CHILD HEALTH CARE; CLINICAL FEATURE; CLINICAL GENETICS; CLINICAL TRIAL; CROHN DISEASE; DISEASE COURSE; DRUG BIOAVAILABILITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; ENTERIC FEEDING; ENTERITIS; EVIDENCE BASED MEDICINE; GENETIC VARIABILITY; HEPATOSPLENIC T CELL LYMPHOMA; HUMAN; MONOTHERAPY; ONSET AGE; PATHOGENESIS; PEDIATRICS; PHENOTYPE; REVIEW; SEX DIFFERENCE; T CELL LYMPHOMA; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT; UPPER GASTROINTESTINAL TRACT;

CHILD; COLITIS, ULCERATIVE; CROHN DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; TREATMENT OUTCOME;

EID: 70350749721     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2009.07.010     Document Type: Review

References (60)

1. Van Limbergen J., Russell R.K., Drummond H.E., et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 135 (2008) 1114-1122
2. Vernier-Massouille G., Balde M., Salleron J., et al. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology 135 (2008) 1106-1113
3. Mamula P., Telega G.W., Markowitz J.E., et al. Inflammatory bowel disease in children 5 years of age and younger. Am J Gastroenterol 97 (2002) 2005-2010
4. Biank V., Broeckel U., and Kugathasan S. Pediatric inflammatory bowel disease: clinical and molecular genetics. Inflamm Bowel Dis 13 (2007) 1430-1438
5. Satsangi J. Gene discovery in IBD: a decade of progress. J Pediatr Gastroenterol Nutr 46 suppl 1 (2008) E1-E2
6. Barrett J.C., Hansoul S., Nicolae D.L., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40 (2008) 955-962
7. Peterson N., Guthery S., Denson L., et al. Genetic variants in the autophagy pathway contribute to paediatric Crohn's disease. Gut 57 (2008) 1336-1337 [author reply 1337]
8. Essers J.B., Lee J.J., Kugathasan S., et al. Established genetic risk factors do not distinguish early and later onset Crohn's disease. Inflamm Bowel Dis 15 10 (2009) 1508-1514
9. Kugathasan S., Baldassano R.N., Bradfield J.P., et al. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet 40 (2008) 1211-1215
10. Jose F.A., Garnett E.A., Vittinghoff E., et al. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 15 (2009) 63-68
11. Griffiths A.M., Nguyen P., Smith C., et al. Growth and clinical course of children with Crohn's disease. Gut 34 (1993) 939-943
12. Hildebrand H., Karlberg J., and Kristiansson B. Longitudinal growth in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 18 (1994) 165-173
13. Kanof M.E., Lake A.M., and Bayless T.M. Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease. Gastroenterology 96 (1988) 1523-1527
14. Markowitz J., Grancher K., Rosa J., et al. Growth failure in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 16 (1993) 368-369
15. Kirschner B.S. Growth and development in chronic inflammatory bowel disease. Acta Paediatr Scand Suppl 366 (1990) 98-104
16. Pfefferkorn M., Burke G., Griffiths A., et al. Growth abnormalities persist in newly diagnosed children with Crohn disease despite current treatment paradigms. J Pediatr Gastroenterol Nutr 48 (2009) 168-174
17. Benchimol E.I., Seow C.H., Steinhart A.H., et al. Traditional corticosteroids for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2 (2008) CD006792. DOI: 10.1002/14651858
18. Seow C.H., Benchimol E.I., Griffiths A.M., et al. Budesonide for induction of remission in Crohn's disease. Cochrane Database Syst Rev 3 (2008) CD000296. DOI: 10.1002/14651858
19. Benchimol E.I., Seow C.H., Otley A.R., et al. Budesonide for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 1 (2009) CD002913. DOI: 10.1002/14651858
20. Truelove S.C., and Jewell D.P. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1 (1974) 1067-1070
21. Faubion Jr. W.A., Loftus Jr. E.V., Harmsen W.S., et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 121 (2001) 255-260
22. Zachos M., Tondeur M., and Griffiths A.M. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev 1 (2007) CD000542. DOI: 10.1002/14651858
23. Borrelli O., Cordischi L., Cirulli M., et al. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol 4 (2006) 744-753
24. Takagi S., Utsunomiya K., Kuriyama S., et al. Effectiveness of an 'half elemental diet' as maintenance therapy for Crohn's disease: a randomized-controlled trial. Aliment Pharmacol Ther 24 (2006) 1333-1340
25. Akobeng A.K., and Thomas A.G. Enteral nutrition for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 3 (2007) CD005984. DOI: 10.1002/14651858
26. Hanauer S.B., and Stromberg U. Oral Pentasa in the treatment of active Crohn's disease: a meta-analysis of double-blind, placebo-controlled trials. Clin Gastroenterol Hepatol 2 (2004) 379-388
27. Akobeng A.K., and Gardener E. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's Disease. Cochrane Database Syst Rev 1 (2005) CD003715. DOI: 10.1002/14651858
28. Sutherland L., and MacDonald J.K. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2 (2003) CD000543. DOI: 10.1002/14651858
29. Sutherland L., and Macdonald J.K. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2 (2006) CD000544. DOI: 10.1002/14651858
30. Alfadhli A.A., McDonald J.W., and Feagan B.G. Methotrexate for induction of remission in refractory Crohn's disease. Cochrane Database Syst Rev 4 (2005) CD003459. DOI: 10.1002/14651858
31. Feagan B.G., Rochon J., Fedorak R.N., et al. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med 332 (1995) 292-297
32. Uhlen S., Belbouab R., Narebski K., et al. Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study. Inflamm Bowel Dis 12 (2006) 1053-1057
33. Turner D., Grossman A.B., Rosh J., et al. Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease. Am J Gastroenterol 102 (2007) 2804-2812 [quiz 2803, 2813]
34. Prefontaine E., Sutherland L.R., Macdonald J.K., et al. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 1 (2009) CD000067. DOI: 10.1002/14651858
35. Markowitz J., Grancher K., Kohn N., et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 119 (2000) 895-902
36. Weiss B., Lerner A., Shapiro R., et al. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues. J Pediatr Gastroenterol Nutr 48 (2009) 526-530
37. Chande N., MacDonald J.K., and McDonald J.W. Methotrexate for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 4 (2007) CD006618. DOI: 10.1002/14651858
38. Ei-Matary W., Vandermeer B., and Griffiths A.M. Methotrexate for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 3 (2009) CD007560. DOI: 10.1002/14651858
39. Kader H.A., Mascarenhas M.R., Piccoli D.A., et al. Experiences with 6-mercaptopurine and azathioprine therapy in pediatric patients with severe ulcerative colitis. J Pediatr Gastroenterol Nutr 28 (1999) 54-58
40. Behm B.W., and Bickston S.J. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 1 (2008) CD006893. DOI: 10.1002/14651858
41. Akobeng A.K., and Zachos M. Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease. Cochrane Database Syst Rev 4 (2004) CD003574. DOI: 10.1002/14651858
42. Hyams J., Crandall W., Kugathasan S., et al. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology 132 (2007) 863-873 [quiz 1165-6]
43. Hyams J.S., Lerer T., and Griffiths A. Long-term outcome of maintenance infliximab therapy in children with Crohn's disease. Inflammatory Bowel Dis 15 (2009) 816-822
44. Ruemmele F.M., Lachaux A., Cezard J.P., et al. Efficacy of infliximab in pediatric Crohn's disease: a randomized multicenter open-label trial comparing scheduled to on demand maintenance therapy. Inflamm Bowel Dis 15 (2009) 388-394
45. Lawson M.M., Thomas A.G., and Akobeng A.K. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 3 (2006) CD005112
46. Heuschkel R., Salvestrini C., Beattie R.M., et al. Guidelines for the management of growth failure in childhood inflammatory bowel disease. Inflamm Bowel Dis 14 (2008) 839-849
47. Hyams J.S., Ferry G.D., Mandel F.S., et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 12 (1991) 439-447
48. Turner D., Otley A.R., Mack D., et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 133 (2007) 423-432
49. Kugathasan S., and Cohen S. Searching for new clues in inflammatory bowel disease: tell tales from pediatric IBD natural history studies. Gastroenterology 135 (2008) 1038-1041
50. Kugathasan S., Judd R.H., Hoffmann R.G., et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr 143 (2003) 525-531
51. Kappelman M.D., Rifas-Shiman S.L., Kleinman K., et al. The prevalence and geographic distribution of Crohn's Disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 5 (2007) 1424-1429
52. Herrinton L.J., Liu L., Lafata J.E., et al. Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings. Inflamm Bowel Dis 13 (2007) 451-461
53. Sawczenko A., Sandhu B.K., Logan R.F.A., et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 357 (2001) 1093-1094
54. Newby E.A., Croft N.M., Green M., et al. Natural history of paediatric inflammatory bowel diseases over a 5-year follow-up: a retrospective review of data from the register of paediatric inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 46 (2008) 539-545
55. Sawczenko A., Lynn R., and Sandhu B.K. Variations in initial assessment and management of inflammatory bowel disease across Great Britain and Ireland. Arch Dis Child 88 (2003) 990-994
56. Auvin S., Molinie F., Gower-Rousseau C., et al. Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999). J Pediatr Gastroenterol Nutr 41 (2005) 49-55
57. Heyman M.B., Kirschner B.S., Gold B.D., et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr 146 (2005) 35-40
58. Sawczenko A., and Sandhu B.K. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child 88 (2003) 995-1000
59. Hyams J.S., Davis P., Grancher K., et al. Clinical outcome of ulcerative colitis in children. J Pediatr 129 (1996) 81-88
60. Hyams J., Markowitz J., Lerer T., et al. The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol 4 (2006) 1118-1123